Connect_Wealth_logo_Gray_Bly@300x.png

World Family Office Forum -

Virtual 2021

Sign Up to the Sessions of Your Interest!

Please indicate which of the Panel Discussions and Presentations you would like to attend below;

DAY TWO: Friday 26th March

08:00 CET: Panel Discussion: Southeast Asia - The Next Fast-Growing VC Market?

Moderator:

Arshad Chowdhury, Managing Partner, Betatron

Panellists:

Aradhna Dayal, Founder & CEO, Access Alts Asia

Meng-Han Kuok, Founder & CEO, CAMTECH

 

- What’s driving innovation and growth in Southeast Asia markets?

- Which markets and sectors should be considered by Family Office investors?

- What are the current VC investment trends in Southeast Asia?

- A look at the risks and challenges moving forward

08:40 CET: Keynote presentation: Enabling VC 3.0: Enabling High Quality Dealflows for Family Offices

John Sharp, Partner, Hatcher+

Discover insights from founding partner, John Sharp behind Hatcher+ data-driven approach to venture investing that delivers robust, predictable returns, access to high quality global dealflows and co-investment opportunities for family offices.

09:30 CET: Roundtable Discussion: Singapore: A Global Real Estate Haven

Marcus Loo, CEO, Singapore, Savills

Jacqueline Wong, Executive Director, Savills

Savills Private Office proudly introduces Singapore as the destination for International Family Offices to headquarter in Asia. The highly acclaimed Garden City state is renowned for its diversity in people and assets alike. Real estate, infrastructure, security and governance are one of many luring factors to setup shop in Singapore.

12:00 CET: Roundtable Discussion: Investing in a Unique Healthcare and Bio-Convergence Venture Capital

Assaf Barnea, CEO, Sanara Ventures

Uri Adoni, General Partner, Sanara Capital

Sanara Capital is a $100M Digital Health & Bio-Convergence venture fund focusing on Series A+B opportunities in Israeli related companies and the follow-on fund of Sanara Ventures. Sanara Capital enjoys preemptive rights in all Sanara Ventures' portfolio companies. Independent and non-biased investment decisions by the GP’s, cherry picking only the best opportunities from Sanara Ventures' portfolio and external companies. Sanara Capital portfolio companies enjoys Sanara Ventures’ existing relationships with global network of physicians, KOL’s, hospitals and payers. Access to capital from a global network of life science VC’s and CVC’s. Philips & Teva continuing commitment for the portfolio companies. Building on Sanara Ventures brand. Philips has committed to be the anchor investor of Sanara Capital.

14:00 CET: Panel Discussion: Healthcare Investments - New Opportunities, New Challenges

Moderator:

Assaf Barnea, CEO, Sanara Ventures

Panellists:

Talal Alajou - Chief Investment Officer, Elajou Group

Dr. Ruchi Dana, Partner, Dana Family Office

Dr. Shawn Iadonato, PhD, CEO, Kineta

 

- Which subsets and markets hold the most promise for investment?

- A look at the major themes driving healthcare investment

- How changes in the sector are affecting the broader investment landscape

- What new opportunities are opening up for Family Office investors?

14:40 CET: Keynote Presentation: Cancer Innovation and Impact Investing

Dr. Shawn Iadonato, PhD, CEO, Kineta

Cancer is a major public health problem worldwide and is the second leading cause of death in the US. Over 20M people in the US are living with cancer today. There is an urgent medical need for innovative new drug treatments to improve cancer survival rates and Kineta is working to solve this problem.

16:00 CET: Panel Discussion: Cannabis - Is the Grass Greener for Investors?

Moderator:

Geoff Trotter, Co-Founder/Chief Growth Officer, Regennabis

Panellists:

Rob Sechrist, President, Pelorus Equity Group

Matt Hawkins, Founder & Managing Principal, Entourage Effect Capital (EEC)

 

- What’s driving the growth of the legal cannabis sector?

- Why are asset valuations currently so attractive given the growth potential?

- Why is the timing good now for family offices to invest?

- What’s the legality of investing in the cannabis sector?

16:40 CET: Keynote Presentation: Investing in the United States Cannabis Market. What Has Changed Since 2014 Until Now, And What Does the Future Look Like?

Matt Hawkins, Founder & Managing Principal, Entourage Effect Capital (EEC)

Cancer is a major public health problem worldwide and is the second leading cause of death in the US. Over 20M people in the US are living with cancer today. There is an urgent medical need for innovative new drug treatments to improve cancer survival rates and Kineta is working to solve this problem.

17:30 CET: Panel Discussion: Tech Mega Trends

Moderator:

Brian DeFee, Director of Corporate Development, Top Tier Capital Partners

Panellists:

Alisee De Tonnac, Co-Founder & Partner, Seedstars Group

Caroline Walerud, Partner, Walerud Ventures

Ndiawar Sar, Director, Forestay Capital SA

David York, Managing Director, Top Tier Capital Partners

 

- What are the tech trends that will change the world?

- Accessing the right private market deals. How to overcome the challenges?

- When does it makes sense to be a contrarian investor in technology?

- Fund or Direct Investments as a Family Office?

18:10 CET: Keynote Presentation: State of the Global Venture Capital Markets in 2021

David York, Managing Director, Top Tier Capital Partners

David York will be speaking about the state of the global venture capital market, which has seen considerable tailwinds as of late. Mr. York will discuss VC performance relative to other markets, money flows into the asset class, as well as provide some insights regarding increased valuations and the rise of SPACs in the United States.